Maria Luisa De Perna
Overview
Explore the profile of Maria Luisa De Perna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caporali E, Paone G, Moschovitis G, De Perna M, Lo Priore E, Bernasconi E, et al.
Echocardiography
. 2024 Oct;
41(11):e15934.
PMID: 39440911
Infective endocarditis and infection of cardiac devices are conditions characterized by high morbidity and mortality, thus requiring a prompt diagnosis. Advanced imaging modalities are often required in the management of...
2.
Carmine D, Aeschbacher S, Coslovsky M, Hennings E, Paladini R, Peter R, et al.
Front Cardiovasc Med
. 2024 Sep;
11:1449506.
PMID: 39314770
Background: The influence of atrial fibrillation (AF) and blood pressure (BP) on brain lesions and cognitive function is unclear. We aimed to investigate the association of BP with different types...
3.
Aebersold H, Foster-Witassek F, Aeschbacher S, Beer J, Blozik E, Blum M, et al.
Open Heart
. 2024 Feb;
11(1).
PMID: 38302139
Aims: Direct-acting oral anticoagulants (DOACs) have, to a substantial degree, replaced vitamin K antagonists (VKA) as treatments for stroke prevention in atrial fibrillation (AF) patients. However, evidence on the real-world...
4.
Wueest A, Zuber P, Coslovsky M, Rommers N, Rodondi N, Gencer B, et al.
Front Cardiovasc Med
. 2023 Aug;
10:1212587.
PMID: 37600058
Background: Longitudinal association studies of atrial fibrillation (AF) and cognitive functions have shown an unclear role of AF-type and often differ in methodological aspects. We therefore aim to investigate longitudinal...
5.
Hennings E, Blum S, Aeschbacher S, Coslovsky M, Knecht S, Eken C, et al.
J Am Heart Assoc
. 2023 Mar;
12(6):e028255.
PMID: 36926939
Background Patients with atrial fibrillation (AF) face an increased risk of death and major adverse cardiovascular events (MACE). We aimed to assess the predictive value of the novel atrial-specific biomarker...
6.
Blumetti L, De Perna M, Reinehr M, Pedrazzini G
Eur Heart J Case Rep
. 2021 Nov;
5(10):ytab399.
PMID: 34738066
Background: Eosinophilic myocarditis (EM) is a rare and potentially life-threatening form of myocarditis, frequently (but not always) associated with eosinophilia, and presents with acute chest pain, or signs and symptoms...
7.
Moschovitis G, Johnson L, Blum S, Aeschbacher S, De Perna M, Pagnamenta A, et al.
Open Heart
. 2021 Apr;
8(1).
PMID: 33883229
Objective: The optimal target heart rate in patients with prevalent atrial fibrillation (AF) is not well defined. The aim of this study was to analyse the associations between heart rate...
8.
Benz A, Aeschbacher S, Krisai P, Moschovitis G, Blum S, Meyre P, et al.
J Am Heart Assoc
. 2021 Apr;
10(8):e019168.
PMID: 33843247
Background Hospitalization for heart failure (HF) is very common in patients with atrial fibrillation (AF). We hypothesized that biomarkers of inflammation can identify patients with AF at increased risk of...